Pfizer/BioNTech’s Comirnaty Supply Agreements Unaffected Despite EU Green Light For Under-12s
Comirnaty To Be First EU Approved Vaccine For 5 to 11 Year-Olds.
Pfizer and BioNTech’s Comirnaty supply under existing agreements will continue as planned despite anticipated expansion into a new child sub-population in Europe.
You may also be interested in...
The EMA is going all out to maximize coverage of the EU population with both vaccines and treatments for COVID-19.
The latest round-up from the Pink Sheet of developments relating to COVID-19.
The UK biotech has struck up an unusual deal with its new investor that lets it retain control over its assets, as it raises $54m in a series A.